Vanja Vlajnic

445 citations
6 papers · 226 indexed · 1 hit paper · h-index 5
Topics
Heart Failure Treatment and Management (5 papers)Cardiovascular Function and Risk Factors (4 papers)Hemodynamic Monitoring and Therapy (1 paper)
Journals
JAMASHILAP Revista de lepidopterologíaEuropean Journal of Heart Failure

In The Last Decade

Vanja Vlajnic

6 papers receiving 223 citations

Hit Papers

Effect of Vericiguat vs Placebo on Quality of Life in Pat...2020202620222024202050100150

Peers

Vanja Vlajnic
Comparison fields: 5 of 44
  • Cardiology and Cardiovascular Medicine 199
  • Endocrinology, Diabetes and Metabolism 44
  • Molecular Biology 31
  • Physiology 30
  • Pulmonary and Respiratory Medicine 26
Replace Ian J. Kulac with:
Ian J. Kulac United States
Jelena Seferović United States
Adriaan A. Voors Netherlands
Hossein Shenasa United States
Romain Boulestreau France
Manuel Reyes United States
Sanjiv J Shah United States
Jonathan H. Ward United States
Yifen Lin China
Prafull Raheja United States
Vanja Vlajnic relative to Ian J. Kulac United States Ian J. Kulac's profile →
Citations per field
00.5×5.9×
Ian J. Kulac · 1×
Citations per year

Countries citing papers authored by Vanja Vlajnic

Since Specialization
Citations

This map shows the geographic impact of Vanja Vlajnic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanja Vlajnic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanja Vlajnic more than expected).

Fields of papers citing papers by Vanja Vlajnic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanja Vlajnic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanja Vlajnic. The network helps show where Vanja Vlajnic may publish in the future.

Co-authorship network of co-authors of Vanja Vlajnic

This figure shows the co-authorship network connecting the top 25 collaborators of Vanja Vlajnic. A scholar is included among the top collaborators of Vanja Vlajnic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanja Vlajnic. Vanja Vlajnic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 1
2 5
3 5
4 24
5 7
6
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fractionbreakdown →
184

About Vanja Vlajnic

Vanja Vlajnic is a scholar working on Cardiology and Cardiovascular Medicine, Statistics, Probability and Uncertainty and Complementary and alternative medicine, having authored 6 papers that have together received 226 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Hemodynamic Monitoring and Therapy (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (199 citations), Endocrinology, Diabetes and Metabolism (44 citations) and Complementary and alternative medicine (13 citations). Vanja Vlajnic has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Lothar Roessig, Burkert Pieske, Piotr Ponikowski, Paul W. Armstrong, Kevin J. Anstrom, Carolyn S.P. Lam, Robert O. Blaustein, Javed Butler, Scott D. Solomon and Justin A. Ezekowitz. Their work appears in journals such as JAMA, SHILAP Revista de lepidopterología and European Journal of Heart Failure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026